About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...

In this Oct. 7, 2019, file photo, a pharmacist displays the HIV prevention drugs Descovy, left and Truvada, right, at a pharmacy in Sacramento, Calif. A proposed federal policy aims to protect older ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

CVS cites clinical, financial, and regulatory reasons for decision Yeztugo approved by FDA in June, nearly 100% effective in trials Medicare, VA, some Medicaid plans are already covering the drug CVS ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "The progress that science has made against HIV/AIDS is ...

Oral preexposure prophylaxis (PrEP) has played a significant role in Australia’s reduction of new HIV infections, but experts have sounded the alarm over ongoing challenges. They suggested that new, ...